Howard Hughes Medical Institute’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-26
Closed -$2.62K 119
2025
Q4
$2.62K Hold
26
﹤0.01% 446
2025
Q3
$3.21K Hold
26
﹤0.01% 417
2025
Q2
$3.12K Buy
+26
New +$3.47K ﹤0.01% 418

Other funds holding CLX

Howard Hughes Medical Institute's CLX Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Clorox (CLX) in Q1 2026, closing a stake of 26 shares — an estimated $2.62K sold.

Howard Hughes Medical Institute first reported a position in CLX in Q2 2025 and held it in 3 quarters. The position peaked at $3.21K in Q3 2025. 1,082 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Clorox position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 26 Clorox shares in Q1 2026, an estimated $2.62K.
  • Howard Hughes Medical Institute first reported a position in Clorox in Q2 2025 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Clorox position peaked at $3.21K in Q3 2025.
  • 1,082 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.